Methoxy polyethylene glycol-epoetin beta
Methoxy polyethylene glycol-epoetin beta (also known as Mircera) is a synthetic, continuous erythropoietin receptor activator used in the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia. It is a type of erythropoiesis-stimulating agent (ESA) that stimulates the bone marrow to produce more red blood cells.
Mechanism of Action[edit]
Methoxy polyethylene glycol-epoetin beta works by binding to the erythropoietin receptor on the surface of red blood cell precursors in the bone marrow. This binding activates the receptor and stimulates the production of red blood cells, thereby increasing the overall red blood cell count and improving the symptoms of anemia.
Clinical Use[edit]
Methoxy polyethylene glycol-epoetin beta is used in the treatment of anemia associated with chronic kidney disease, both in patients on dialysis and those not on dialysis. It is also used to treat anemia caused by chemotherapy in patients with certain types of cancer.
Side Effects[edit]
Like all medications, methoxy polyethylene glycol-epoetin beta can cause side effects. The most common side effects include headache, diarrhea, and upper respiratory tract infections. Serious side effects can include high blood pressure, blood clots, and severe allergic reactions.
Dosage and Administration[edit]
Methoxy polyethylene glycol-epoetin beta is administered as an injection under the skin or into a vein. The dosage is determined by the patient's hemoglobin level and overall health status.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
